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r disoproAbstract A new simple spectrophotometric method was recently developed for the determination
of binary mixtures without prior separation. The method is based on generation of ratio spectra of
compound X by using standard spectrum of compound Y as a divisor, then the peak to peak (or
peak to trough) amplitudes between two selected wavelengths in the ratio spectra are found propor-
tional to concentration of X without interference from compound Y. The method was applied for
the determination of the antiviral mixture of emtricitabine (EMT) and tenofovir disoproxil fuma-
rate (TEN). For the determination of EMT, a solution of 15 lg/mL TEN was used as divisor to
generate the ratio spectra, and the peak to trough amplitudes between 228.5 and 260.5 nm were
plotted against EMT concentration. Similarly by using 10 lg/mL EMT as divisor, the peak to
trough amplitudes between 229 and 260 nm were found proportional to TEN concentration. The
reliability and analytical performance of the proposed spectrophotometric procedure were statisti-
cally validated with respect to linearity, range, precision, accuracy, detection and quantiﬁcation lim-
its. Calibration curves were linear in the range of 2–40 lg/mL for both drugs with correlation
coefﬁcients >0.9997. The proposed method was successfully applied for the simultaneous determi-
nation of the two drugs in several laboratory prepared mixtures and in their combined tablet dosage
form.
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One of the main challenges facing analytical chemists is the
spectrophotometric determination of two or more compounds
in the same sample without preliminary separation. Several
spectrophotometric methods have been used for resolving mix-
tures of compounds with overlapping spectra such as deriva-
tive spectrophotometry (Wahbi and Ebel, 1974; Morelli,
1994) Vierordt’s method (Go¨ro¨g, 1995), dual wavelengthing Saud University.
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2 H.K. Ashour, T.S. Belalspectrophotometry (Shibata et al., 1971), pH-induced differ-
ence spectrophotometry (Davidson and Stenlake, 1974),
H-point standard addition method (HPSAM) (Sabry and
Khamis, 2000) and several more sophisticated computerized
and chemometric spectrophotometric methods (Korany
et al.,1986, 1990; Wahbi et al., 1989; El-Gindy et al., 2010).
Generation of absorbance ratio spectra has been the basis
of several analytical procedures for the simultaneous spectro-
photometric determination of compounds in binary and ter-
nary mixtures. First, binary mixtures were resolved using the
ratio-spectra derivative method (Salinas et al., 1990). Then,
this method was modiﬁed and extended for the determination
of ternary mixtures. Examples of these modiﬁed versions are
the derivative ratio spectra zero-crossing method (Berzas
Nevado et al., 1992; Abdel-Hay et al., 2008), the double divisor
ratio spectra derivative method (Dinc¸ and Onur, 1998) and the
successive derivative ratio spectra method (Afkhami and
Bahram, 2005). Furthermore, the ratio spectra were exploited
for the development of other mathematical methods for reso-
lution of binary and ternary mixtures such as the mean center-
ing of ratio spectra method (Abdelwahab et al., 2012), the ratio
subtraction method (El-Bardicy et al., 2008) and the convo-
luted double divisor ratio spectra using combined trigonomet-
ric Fourier functions method (Youssef and Maher, 2008). In
most of these methods, at least two mathematical processes
(e.g. division followed by derivative curve generation) are
needed in order to get measurable amplitude that is correlated
to the concentration of only one compound without interfer-
ence from the others in the mixture. Obviously, some methods
need more sophisticated mathematical treatment to unambig-
uously determine the target compound in the presence of inter-
ferences (El-Bardicy et al., 2008; Youssef and Maher, 2008).
Emtricitabine (EMT) and tenofovir disoproxil fumarate
(TEN) are reverse transcriptase inhibitors with antiviral activ-
ity against HIV-1 and hepatitis B virus. Fixed dose combina-
tion products of the two antiviral drugs for the treatment of
HIV infection have been developed in order to improve patient
adherence and avoid monotherapy, thereby decreasing the risk
of acquired drug resistance (Sweetman, 2009; Truvada web-
page). Several HPLC methods were found in the literature
for the assay of this mixture in human plasma or in tablet dos-
age forms. Detection of both drugs in these methods was
achieved either depending on UV-detection (Karunakaran
et al., 2010; Pendela et al., 2011) or tandem mass spectrometry
(Gomes et al., 2008; Delahunty et al., 2009; Yadav et al., 2010).
HPTLC was also applied for the determination of this binary
mixture (Joshi et al., 2009; Bhirud and Hiremath, 2013). Final-
ly, few spectrophotometric methods were published for the
simultaneous estimation of EMT and TEN in their combined
tablets. These reports recommended the use of area under the
curve and dual wavelength methods (Ghorpade et al., 2010),
simultaneous equations and absorbance ratio methods (Ingale
et al., 2010) and the absorbance correction method and ﬁrst or-
der derivative spectrophotometry (Karunakaran et al., 2011).
Recently, a new ratio spectra peak to peak measurement
method was developed for the determination of binary mix-
tures without prior separation (Belal et al., 2013). The method
employs only one step (dividing the mixture spectra by a stan-
dard divisor spectrum), followed by peak to peak measurement
in the produced ratio spectra. The method eliminates the deriv-
ative step, and does not require searching for zero-crossing
points or any complicated mathematical or chemometric treat-Please cite this article in press as: Ashour, H.K., Belal, T.S. New simple s
of emtricitabine and tenofovir disoproxil fumarate. Arabian Journal ofment of data. This work describes the application of this new
method for the quantiﬁcation of the binary mixture of EMT
and TEN where the two compounds were simultaneously
determined in several laboratory prepared mixtures and in tab-
lets without prior separation.
2. Theoretical background
Consider a mixture of two compounds X and Y. The absorp-
tion spectrum of the mixture-measured in 1 cm pathlength- is
deﬁned by the equation:
AM ¼ XCX þ YCY ð1Þ
where AM is the absorbance of the mixture, eX and eY are the
molar absorptivities of X and Y and CX and CY are the con-
centrations of X and Y. If the absorbance of the mixture is di-
vided by the absorbance of a standard solution of X
(Absorbance AoX = eX C
o
X), the following equation results:
AM
AoX
¼ CX
CoX
þ AY
AXo
ð2Þ
The ratio CX/C
0
X is a constant value which can be eliminated
by taking the difference in absorbance ratio amplitudes be-
tween two wavelengths k1 and k2 (peak to peak measurement):
AM
AoX
 
k1
 AM
AoX
 
k2
¼ AY
AXo
 
k1
 AY
AXo
 
k2
ð3Þ
Eq. (3) illustrates that the difference amplitude in the mixture
absorbance ratio between two wavelengths k1 and k2 (can be
called peak to peak, peak to trough or maximum to minimum
measurement) is equal to the same difference amplitude for
compound Y after canceling the constant interference due to
compound X. In the proposed method, the concentration of
compound Y (CY) is proportional to the peak to peak ampli-
tudes of its absorbance spectra. A calibration graph is ob-
tained by recording and storing the spectra of solutions of
different concentrations of pure Y, and the spectrum of a solu-
tion of pure X (the divisor X). The stored spectra of the solu-
tions of pure Y are divided by the standard spectrum of the
divisor (X). In the generated ratio spectra, the peak to peak
amplitudes between the selected wavelengths k1 and k2 are
measured and plotted against CY to obtain the calibration
graph. By using the calibration graph, the concentration of
compound Y in the mixture is determined after similar treat-
ment for the mixture solution. The concentration of X in the
mixture is determined by an analogous procedure.
3. Experimental
3.1. Apparatus
Spectrophotometric measurements were performed using a
Specord S600 UV/VIS diode array spectrophotometer (scan
speed 6000 nm/min and wavelength interval 0.5 nm), associ-
ated with WinAspect software version 2.3 (Analytik Jena
AG, Germany).
3.2. Materials
Authentic samples of emtricitabine (EMT) and tenofovir
disoproxil fumarate (TEN) were kindly provided by Gileadpectrophotometric method for determination of the antiviral mixture
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for the preparation of all stock and working solutions. The
pharmaceutical preparation assayed in the study is Truvada
tablets (Gilead Sciences Inc., Canada) labeled to contain
200 mg EMT and 300 mg TEN per tablet.
3.3. General procedure
Stock solutions of 200 lg/mL EMT and 200 lg/mL TEN were
prepared in distilled water and stored refrigerated at 4 C. The
working solutions were prepared by dilution of EMT and TEN
stock solutions with distilled water to reach the concentration
range of 2–40 lg/mL for both drugs. The absorbance spectra
were recorded against distilled water in the range of 200–
300 nm and stored. The EMT stored spectra were divided
(amplitude by amplitude at each wavelength) by the spectrum
of the divisor (15 lg/mL TEN). The peak to trough amplitudes
in the EMT ratio spectra between 228.5 and 260.5 nm were
measured and plotted against the corresponding concentra-
tions to construct the calibration graph. Similarly, the stored
absorbance spectra of TEN were divided by the spectrum of
10 lg/mL EMT. The peak to trough amplitudes in the TEN
ratio spectra between 229 and 260 nm were measured and plot-
ted against the corresponding concentrations.
3.4. Applications
3.4.1. Analysis of laboratory prepared mixtures
Aliquots from the previously mentioned stock solutions of
EMT and TEN were used to prepare a series of standard lab-
oratory-prepared mixtures of the two drugs. The mixtures
were diluted to volume with distilled water. Their absorbance
spectra were recorded against distilled water, and the stored
spectra were divided by the spectrum of 15 lg/mL TEN
(for determination of EMT content), and the spectrum ofTable 1 Regression and statistical parameters for the deter-
mination of EMT and TEN using the proposed spectrophoto-
metric method.
Parameter EMT TEN
Wavelengths (nm) 228.5 and 260.5 229.0 and 260.0
Concentration range (lg/mL) 2–40 2–40
Intercept (a) 0.1414 0.0959
Sa
a 0.0292 0.0297
Slope (b) 0.2204 0.1631
Sb
b 0.0019 0.0015
RSD% of the slope (Sb%) 0.8621 0.9197
Correlation coeﬃcient (r) 0.99977 0.99976
Sy/x
c 0.0454 0.0507
Fd 13244 12475
Signiﬁcance F 2.90 · 1011 3.47 · 1011
LODe(lg/mL) 0.4372 0.6009
LOQf(lg/mL) 1.3249 1.8210
a Standard deviation of the intercept.
b Standard deviation of the slope.
c Standard deviation of residuals.
d Variance ratio, equals the mean of squares due to regression
divided by the mean of squares about regression (due to residuals).
e Limit of detection.
f Limit of quantiﬁcation.
Please cite this article in press as: Ashour, H.K., Belal, T.S. New simple sp
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amplitudes were measured (Table 1), and concentrations were
determined using the corresponding calibration graphs.
3.4.2. Analysis of commercial tablets
A total of 5 Truvada tablets were weighed and ﬁnely pow-
dered. To an accurately weighed quantity of the powder equiv-
alent to 40 mg EMT and 60 mg TEN, 50 mL of distilled water
was added, sonicated for 15 min, and then ﬁltered into a 100-
mL volumetric ﬂask. The residue was washed with two 10-mL
portions of distilled water, and the washing solutions were
added to the ﬁltrate and diluted to volume with distilled water.
Aliquots of the tablets’ aqueous extract were diluted with dis-
tilled water to obtain ﬁnal concentrations within the speciﬁed
range (2–40 lg/mL for both drugs) then treated as under Gen-
eral Procedure. Recovery values were calculated from similarly
treated standard solutions. For standard addition assay, sam-
ple solutions were spiked with aliquots of EMT and TEN
stock solutions to obtain total concentrations within the previ-
ously speciﬁed range then treated as under General procedure.
Recovered concentrations were calculated by comparing the
analyte response with the increment response attained after
addition of the standard.
4. Results and discussion
4.1. Development of the spectrophotometric method
The absorbance (zero-order) spectra of EMT and TEN over
the range of 200–300 nm in distilled water are shown in
Fig. 1. Obviously, the UV bands of both drugs are consider-
ably overlapped that conventional spectrophotometric mea-
surement cannot be used for their simultaneous
determination. EMT shows an absorption maximum at about
283 nm which corresponds to minimum interference from
TEN (Fig. 1), however, TEN still contributes to the absorption
of the mixture at this wavelength, therefore the EMT peak at
283 nm cannot be used for its selective determination in the
presence of TEN. On the other hand, the slope region in the
absorption spectrum of EMT above 290 nm shows zero inter-
ference from TEN; therefore it was exploited through applica-
tion of the ﬁrst derivative spectrophotometry for the
determination of EMT at 298 nm (Karunakaran et al., 2011).
Alternatively, to overcome the mutual interference of each
compound in the determination of the other, a simple one-step0
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Figure 1 Absorption spectra of 20 lg/mL EMT and 20 lg/mL
TEN in distilled water.
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was developed. A study was carried out to examine the effect
of divisor concentration on the ratio spectra of EMT and
TEN. When the concentration of divisor is increased or de-
creased, the resulting absorbance ratio values are proportion-
ally decreased or increased, respectively, although the
positions of the peaks and troughs remain unaffected by
changing the divisor concentration. The best results in terms
of signal to noise ratio, sensitivity, accuracy and precision were
obtained by using 15 lg/mL TEN (for EMT) and 10 lg/mL
EMT (for TEN) as divisors.
The ratio spectra of different EMT standards at increasing
concentrations in distilled water, obtained by dividing each by
the spectrum of 15 lg/mL TEN in the same solvent are illus-
trated in Fig. 2. The peak to trough amplitudes between
228.5 and 260.5 nm on the generated ratio spectra are propor-
tional to EMT concentration. Fig. 3 shows the ratio spectra of
a standard solution of EMT and a mixture solution containing
the same concentration of EMT. The difference between the 2
spectra is the constant interference value (the term CX/C
o
X in
Eq. (2)). This interference was eliminated in the Salinas meth-
od (Salinas et al., 1990) by recording the ﬁrst derivative of the
mixture ratio spectrum. Alternatively, the constant interfer-
ence can be eliminated by measurement of the absorbance ra-
tio difference between two selected wavelengths k1 and k2.
Ideally, these selected wavelengths should correspond to the0
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Figure 2 Ratio spectra of 5, 10, 15, 20 and 30 lg/mL EMT.
Divisor is 15 lg/mL TEN. All solutions in distilled water.
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Figure 3 Ratio spectra of 15 lg/mL EMT (––––) and a mixture
of 15 lg/mL EMT+ 10 lg/mL TEN (. . .. . .). Divisor is 15 lg/mL
TEN. All solutions in distilled water.
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the highest sensitivity. Fig. 3 shows that the peak to trough
amplitude in the mixture spectrum is equal to that in standard
EMT spectrum, therefore EMT can be quantiﬁed in the mix-
ture without interference from TEN.
For the determination of TEN, an analogous procedure
was followed. Fig. 4 shows the ratio spectra of different stan-
dards of TEN using 10 lg/mL EMT as divisor. The peak to
trough amplitudes between 229 and 260 nm were measured
and found proportional to TEN concentration. Fig. 5 presents
the ratio spectra of a standard solution of TEN and a mixture
solution containing the same concentration of the drug. It is
evident that the measured peak to trough amplitude in the
mixture spectrum is equal to that in standard TEN spectrum.
4.2. Validation of the proposed spectrophotometric method
4.2.1. Linearity and concentration ranges
The linearity of the proposed spectrophotometric procedure
was evaluated by analyzing a series of different concentrations
of each drug (n= 7). The assays were applied following the
established experimental conditions. The measured peak to
peak amplitudes at the selected wavelengths were found to
be proportional to concentrations of the analyte. The linear
regression equations were generated by least squares treatment
of the calibration data. Table 1 presents the performance data0
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Figure 5 Ratio spectra of 20 lg/mL TEN (––––) and a mixture of
20 lg/mL TEN+ 10 lg/mL EMT (. . .. . .). Divisor is 10 lg/mL
EMT. All solutions in distilled water.
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Figure 4 Ratio spectra of 5, 10, 15, 20 and 30 lg/mL TEN.
Divisor is 10 lg/mL EMT. All solutions in distilled water.
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Table 2 Precision and accuracy for the determination of EMT and TEN in bulk form using the proposed spectrophotometric method.
Analyte Nominal value (lg/mL) Within-day Between-day
Found ± SDa(lg/mL) RSD (%)b Er (%)
c Found ± SDa (lg/mL) RSD (%)b Er (%)
c
EMT 5 4.93 ± 0.03 0.61 1.40 4.91 ± 0.09 1.83 -1.80
10 10.05 ± 0.18 1.79 0.50 9.98 ± 0.19 1.90 -0.20
20 19.83 ± 0.30 1.51 0.85 19.89 ± 0.35 1.76 -0.55
TEN 5 4.91 ± 0.02 0.41 1.80 4.92 ± 0.06 1.22 -1.60
10 9.97 ± 0.13 1.30 0.30 10.03 ± 0.17 1.70 0.30
20 19.97 ± 0.19 0.95 0.15 19.86 ± 0.31 1.56 -0.70
a Mean ± standard deviation for three determinations.
b % Relative standard deviation.
c % Relative error.
New simple spectrophotometric method for determination of the antiviral mixture of emtricitabine and tenofovir 5and statistical parameters including linear regression equa-
tions, concentration ranges, correlation coefﬁcients, standard
deviations of the intercept (Sa), slope (Sb) and standard devia-
tions of residuals (Sy/x). Regression analysis shows good linear-
ity as indicated from the correlation coefﬁcient values
(>0.9997). In addition, deviation around the slope can be fur-
ther evaluated by calculation of the RSD% of the slope (Sb%)
which were found to be less than 1.0%. The analysis of vari-
ance test for the regression lines reveals that, for equal degrees
of freedom, an increase in the variance ratio (F values) means
an increase in the mean of squares due to regression and a de-
crease in the mean of squares due to residuals. The greater the
mean of squares due to regression, the steeper is the regression
line. The smaller the mean of squares due to residuals, the less
is the scatter of experimental points around the regression line.
Consequently, regression lines with high F values (low signiﬁ-
cance F) are much better than those with lower ones. Good
regression lines show high values for both r and F statistical
parameters (Armitage and Berry, 1994).
4.2.2. Limits of detection and quantiﬁcation
According to ICH guidelines (ICH, 2005), the approach based
on the standard deviation of intercept value and the slope of
the calibration graph was used for determining the limits of
detection and quantiﬁcation. The LOD and LOQ values for
the two drugs are presented in Table 1.
4.2.3. Precision and accuracy
In order to assess the within-day (intra-day) precision, as per-
centage relative standard deviation (RSD%) and the within-Table 3 Determination of EMT–TEN laboratory-prepared mixture
Nominal value (lg/mL) Found ± SDa (lg/mL)
EMT TEN EMT TEN
15 5 14.69 ± 0.14 5.06 ±
20 10 19.63 ± 0.25 9.81 ±
15 10 14.72 ± 0.14 9.94 ±
20 20 19.67 ± 0.20 19.79 ±
10 20 9.78 ± 0.16 19.79 ±
a Mean ± standard deviation for ﬁve determinations.
b % Relative standard deviation.
c % Relative error.
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for the proposed method, three replicate determinations at
three different concentration levels were carried out on the
same day. The between-day (inter-day) precision and accuracy
were assessed similarly by calculating the RSD% and Er% val-
ues for three replicate determinations of the same concentra-
tion levels on three consecutive days. Found concentrations
were calculated using the corresponding regression equations
and they were satisfactory. The RSD% and Er% values are
listed in Table 2. These values did not exceed 2% thus indicat-
ing high precision and accuracy for the proposed spectropho-
tometric method.
4.2.4. Stability of solutions
The stability of TEN and EMT standard and sample working
solutions in water during handling was veriﬁed by keeping
them at room temperature for 6 h. No signiﬁcant spectropho-
tometric changes were noticed. The stock solutions were also
stable when kept refrigerated at 4 C for at least one week.
4.3. Applications of the proposed method
4.3.1. Analysis of laboratory-prepared synthetic mixtures
The validity of the proposed method was examined by prepar-
ing several laboratory-prepared mixtures of the two com-
pounds at various concentrations within the speciﬁed
linearity range. The mixtures were prepared in different ratios
both above and below the normal ratio expected in commercial
tablets. The laboratory-prepared mixtures were analyzed
according to the previously described procedure. The analysiss using the proposed spectrophotometric method.
RSD (%)b Er (%)
c
EMT TEN EMT TEN
0.07 0.95 1.38 2.07 1.20
0.07 1.27 0.71 1.85 1.90
0.16 0.95 1.61 1.87 0.60
0.37 1.02 1.87 1.65 1.05
0.15 1.64 0.76 2.20 1.05
ectrophotometric method for determination of the antiviral mixture
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Table 4 Analysis of EMT–TEN mixture in Truvada tablets by the proposed spectrophotometric method and the reference method.
External standard Reference method Standard addition
EMT TEN EMT TEN EMT TEN
% Recovery ± SDa 98.78 ± 0.56 99.14 ± 0.38 99.40 ± 0.47 99.76 ± 0.54 98.59 ± 0.59 99.04 ± 0.40
RSD (%)b 0.57 0.38 0.47 0.54 0.60 0.40
t 1.86 1.89
F 1.42 2.02
Theoretical values for t and F at P= 0.05 are 2.31 and 6.39, respectively.
a Mean ± standard deviation for ﬁve determinations.
b % Relative standard deviation.
6 H.K. Ashour, T.S. Belalresults including recovered concentrations, RSD% and Er%
values shown in Table 3 were satisfactory thus validating the
precision and accuracy of the developed method and demon-
strating its capability to resolve and quantify the two drugs
in different ratios.
4.3.2. Analysis of commercial tablets
The developed spectrophotometric procedure was applied for
the assay of the antiviral combination in its commercial prod-
uct (Truvada tablets). The active ingredients were extracted
with distilled water then dilution was made with the same sol-
vent to reach concentration levels within the speciﬁed range.
The studied drugs were directly quantiﬁed without any inter-
ference from the inactive ingredients (croscarmellose sodium,
lactose monohydrate, magnesium stearate, microcrystalline
cellulose, and pregelatinized starch) [22], which indicates the
selectivity of the method. Recoveries were calculated using
both external standard and standard addition methods. The
assay results revealed satisfactory accuracy and precision as
indicated from% recovery, SD and RSD% values (Table 4).
Furthermore, a reference dual wavelength spectrophotometric
method was applied for the estimation of EMT and TEN in
their combined formulation (Ghorpade et al., 2010). Recovery
data obtained from the developed spectrophotometric method
were statistically compared with those of the reference method
using Student’s t- and the variance ratio F-tests. In both tests,
the calculated values did not exceed the theoretical ones at the
95% conﬁdence level which indicated that there were no signif-
icant differences between the recoveries obtained from the
developed method and those of the reference method (Table 4).
It is evident from these results that the proposed method is
applicable to the assay of this drug combination with mini-
mum sample preparation, cost and time-effectiveness and sat-
isfactory level of accuracy and precision.
5. Conclusion
This work presents a novel simple spectrophotometric proce-
dure for the analysis of binary drug mixtures without prior
separation. The method eliminates the derivative step in the
conventional ratio-spectra derivative method (Salinas meth-
od), and does not require searching for zero-crossing points
as in traditional derivative spectrophotometry. It is also much
simpler than the ratio subtraction method as it does not in-
volve the sequential order of manipulations of division, con-
stant subtraction and multiplication. The proposed method
does not include the tedious search for two wavelengths wherePlease cite this article in press as: Ashour, H.K., Belal, T.S. New simple s
of emtricitabine and tenofovir disoproxil fumarate. Arabian Journal ofthe interfering compound shows the same absorptivity as in
the dual wavelength method. Besides, it does not require any
sophisticated mathematical or chemometric treatment for the
absorption data. The method involves the generation of absor-
bance ratio spectra followed by measurement of the peak to
peak (peak to trough) amplitudes. The proposed method was
applied for the simultaneous determination of the two HIV-1
reverse transcriptase inhibitors Emtricitabine and Tenofovir
in their drug combination. The proposed method is time sav-
ing, economic and environmentally-friendly (green method)
since no chemical reagents or organic solvents were used,
and only water was used as solvent for preparation of all solu-
tions in this study. Compared to the previously reported spec-
trophotometric methods for this mixture, the proposed
method is advantageous regarding simplicity of operation
and sensitivity of measurement. The developed method does
not require elaborate treatment, sophisticated experimental
setup or consumption of organic solvents usually associated
with HPLC and HPTLC methods of analysis, however the
developed method lacks the speciﬁcity advantage of separation
methods, and obviously cannot be applied in complex multi-
component mixtures. The applicability of the developed meth-
od was evaluated through the determination of this antiviral
drug combination in several laboratory-prepared mixtures
and in pharmaceutical tablets with good accuracy and preci-
sion, therefore it can be considered as an alternative tool for
the routine analysis of this ﬁxed dose combination with mini-
mum sample preparation.
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